Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion

Rui Su1, Lei Dong1, Yangchan Li2

  • 1Department of Systems Biology, Beckman Research Institute of City of Hope, Monrovia, CA 91016, USA.

Cancer Cell
|June 13, 2020
PubMed

Insights

Fat mass and obesity-associated protein (FTO) inhibitors show potent anti-tumor effects. Targeting FTO suppresses cancer stem cell self-renewal and enhances immune response, offering new therapeutic strategies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Fat mass and obesity-associated protein (FTO) is an RNA demethylase implicated in oncogenesis.
  • FTO's role in cancer presents a target for novel therapeutics.

Purpose of the Study:

  • To develop and evaluate small-molecule FTO inhibitors for cancer therapy.
  • To investigate the impact of FTO inhibition on cancer stem cell self-renewal and immune response.

Main Methods:

  • Development of two potent small-molecule FTO inhibitors.
  • Assessment of anti-tumor effects in various cancer types.
  • Genetic and pharmacological FTO inhibition in leukemia models.
  • Analysis of immune checkpoint gene expression and T cell cytotoxicity.

Main Results:

  • FTO inhibitors demonstrated significant anti-tumor activity across multiple cancer types.
  • FTO inhibition reduced leukemia stem/initiating cell self-renewal.
  • FTO suppression reprogrammed immune response by downregulating immune checkpoint genes, notably LILRB4.
  • FTO inhibition sensitized leukemia cells to T cell-mediated killing and overcame immune evasion.

Conclusions:

  • FTO plays a crucial role in cancer stem cell self-renewal and immune evasion.
  • Targeting FTO with small-molecule inhibitors offers a promising therapeutic strategy for various cancers, particularly leukemia.
  • FTO inhibition can enhance anti-cancer immunity and overcome treatment resistance.

Related Concept Videos

Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
9.3K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.6K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.7K
Replicative Cell Senescence02:15

Replicative Cell Senescence

Replicative cell senescence is a property of cells that allows them to divide a finite number of times throughout the organism's lifespan while preventing excessive proliferation. Replicative senescence is associated with the gradual loss of the telomere — short, repetitive DNA sequences found at the end of the chromosomes. Telomeres are bound by a group of proteins to form a protective cap on the ends of chromosomes. Embryonic stem cells express telomerase — an enzyme that adds...
4.2K